Skip to main content
Lab in Liverpool)


Manufacturing and supply

We operate advanced production facilities in the US, the UK and Australia, and manufacture influenza vaccine using both egg- and cell-based technologies.

For more information about CSL Seqirus Global Manufacturing visit our global website,

CSL privacy statement
CSL privacy statement

This website contains content which is for New Zealand healthcare professionals only. By selecting this box you acknowledge that you are a new Zealand healthcare professional and accessing this website within the scope of your daily practice.